Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

SkyePharma and Bioglan establish marketing agreement for Solarase

March 23, 2000

FDA approves modifications to Dermagraft IDE for diabetic foot ulcers

March 23, 2000

Pharmadigm reports phase II results for DHEAS in burn patients

March 22, 2000

Chrysalin accelerates fracture healing in preclinical animal studies

March 22, 2000

Phase I trial results presented for IDEC-114 antibody in psoriasis

March 21, 2000

AstraZeneca pipeline includes novel chemokine receptor modulators

March 20, 2000

Advanced Tissue Sciences restructures joint venture for Dermagraft during Q4

March 16, 2000

NicOx begins clinical trials of HCT-1026 for dermatology indications

March 15, 2000

Tricyclic 5alpha-reductase inhibitors designed at Merck & Co.

March 14, 2000

Phase III trial of Anogesic as treatment for anal fissure pain commences

March 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...